[1]
Fang, Y. 2026. Advances in the Clinical Application of Novel PCSK9 Inhibitors for High-Risk Atherosclerotic Cardiovascular Disease. International Journal of Biology and Life Sciences. 16, 1 (Aug. 2026), 15–25. DOI:https://doi.org/10.54097/wp0rhk16.